The presence of gamma' chain impairs fibrin polymerization.

Abstract:

INTRODUCTION:A fraction of fibrinogen molecules contain an alternatively spliced variant chain called gamma'. Plasma levels of this variant have been associated with both myocardial infarction and venous thrombosis. Because clot structure has been associated with cardiovascular risk, we examined the effect of gamma' chain on clot structure. MATERIALS AND METHODS:We expressed three fibrinogen variants in Chinese hamster ovary (CHO) cells: gamma/gamma homodimer, gamma/gamma' heterodimer, and gamma'/gamma' homodimer. We observed thrombin-catalyzed fibrinopeptide release by HPLC, fibrin polymerization by turbidity, and clot structure by scanning electron microscopy. We characterized post-translational modifications by mass spectrometry. RESULTS:Fibrinopeptide A was released at the same rate for all three fibrinogens, while fibrinopeptide B was released faster from the gamma'/gamma' homodimer. The rise in turbidity was slower and final absorbance was lower during polymerization of gamma'-containing fibrinogens than for gamma/gamma fibrinogen. Micrographs showed that gamma'/gamma' fibrin clots are composed of very thin fibers, while the diameter of gamma/gamma' fibers is similar to gamma/gamma fibers. Further, the fiber networks formed from gamma'-containing samples were non-uniform. Mass spectrometry showed heterogeneous addition of N-glycans and tyrosine sulfation in the gamma' chain. CONCLUSIONS:The presence of gamma' chains slows lateral aggregation and alters fibrin structure. We suggest these changes are likely due to charge-charge repulsion, such that polymerization of the gamma'/gamma' homodimer is more impaired than the heterodimer since these repulsions are partially offset by incorporation of gamma chains in the gamma/gamma' heterodimer.

journal_name

Thromb Res

journal_title

Thrombosis research

authors

Gersh KC,Nagaswami C,Weisel JW,Lord ST

doi

10.1016/j.thromres.2008.11.016

subject

Has Abstract

pub_date

2009-07-01 00:00:00

pages

356-63

issue

3

eissn

0049-3848

issn

1879-2472

pii

S0049-3848(08)00544-6

journal_volume

124

pub_type

杂志文章
  • Splice variants of Tissue Factor and integrin-mediated signaling.

    abstract::Full-length Tissue Factor (flTF) - the obligatory co-factor for the serine protease (factor) VII/VIIa - serves as the initiator of blood coagulation. The flTF/VIIa complex triggers a sequence of proteolytic events that lead to the formation of a hemostatic plug. Aside from hemostatic maintenance, flTF can contribute t...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2012.02.027

    authors: Srinivasan R,Bogdanov VY

    更新日期:2012-05-01 00:00:00

  • Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type II patients.

    abstract::Alterations in the synthesis or enhanced inactivation of nitric oxide (NO) and an increase in endothelin-1 production lead to an imbalance that can induce arterial hypertension. Type II diabetes is characterized by impaired endothelium-dependent vasodilation and vascular disease. NO is produced through L-arginine path...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00237-7

    authors: Ouviña SM,La Greca RD,Zanaro NL,Palmer L,Sassetti B

    更新日期:2001-04-15 00:00:00

  • GDF-15 is associated with thrombus burden in patients with deep venous thrombosis.

    abstract:INTRODUCTION:Growth differentiation factor-15 (GDF-15) has been identified as a predictor in cardiovascular diseases and acute pulmonary embolism. However, the association of GDF-15 and deep venous thrombosis (DVT) remains unclear. This study aimed to investigate levels of GDF-15 in patients with DVT, and determine its...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.01.022

    authors: Liang W,Wei F,Yang C,Xie F,Shuai XX,Wang M,Yu M

    更新日期:2020-03-01 00:00:00

  • High levels of endothelial and platelet microvesicles in patients with type 1 diabetes irrespective of microvascular complications.

    abstract:INTRODUCTION:Patients with type 1 diabetes have high risk of developing microvascular complications, and microangiopathy contributes to premature cardiovascular disease in this population. The role that microvesicles (MVs) may play in the development of microangiopathy in type 1 diabetes remains unclear. MATERIALS AND...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2020.08.012

    authors: Bergen K,Mobarrez F,Jörneskog G,Wallén H,Tehrani S

    更新日期:2020-12-01 00:00:00

  • Evidence for a saturable mechanism of disappearance of standard heparin in rabbits.

    abstract::This work demonstrates that after bolus intravenous injection standard heparin (SH) disappearance results from the combination of a saturable and a non saturable mechanism. Pharmacokinetics and pharmacodynamics of SH were studied by measuring the disappearance of increasing doses (5 - 500 anti-factor Xa U/kg) of 125I-...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(87)90075-2

    authors: Boneu B,Caranobe C,Gabaig AM,Dupouy D,Sie P,Buchanan MR,Hirsh J

    更新日期:1987-06-15 00:00:00

  • Purification and some properties of a protein obtained from normal human plasma which inhibits the platelet aggregation induced by thrombotic thrombocytopenic purpura plasma.

    abstract::Plasma from patients with thrombotic thrombocytopenic purpura (TTP) caused the aggregation of washed human platelets, which was inhibited by preincubation with normal plasma. Using salt fractionation, ion exchange chromatography, and preparative agarose gel electrophoresis, we purified a protein from normal plasma whi...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90155-5

    authors: Lian EC,Mui PT,Siddiqui FA,Chiu LL

    更新日期:1984-01-01 00:00:00

  • Adhesion of activated platelets to polymorphonuclear leukocytes.

    abstract::Polymorphonuclear leukocytes (PMNL) are components of the blood which as such interact extensively with other blood cells, with endothelial cells or with plasma. Here, we consider the interaction between PMNL and platelets which is efficient during adhesion of platelets to PMNL and which can be studied in vitro using ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(10)80005-2

    authors: Spangenberg P

    更新日期:1994-01-01 00:00:00

  • Factors affecting the first recurrence of noncardioembolic ischemic stroke.

    abstract::Studies of the factors affecting the first recurrence of ischemic stroke have reported inconsistent findings. Types of initial stroke and the racial differences in study samples are among the explanations that may account for this inconsistency. The aims of this study were to estimate the cumulative recurrence rates o...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(99)00146-2

    authors: Wu TH,Chen HH,Lee TK

    更新日期:2000-02-01 00:00:00

  • Association between insurance status, anticoagulation quality, and clinical outcomes in patients with acute venous thromboembolism.

    abstract:INTRODUCTION:A higher level of health insurance coverage may be related to better quality of care and outcomes. Whether insurance status is associated with anticoagulation quality and clinical outcomes in patients with venous thromboembolism (VTE) is unknown. METHODS:We studied 819 elderly patients treated with vitami...

    journal_title:Thrombosis research

    pub_type: 杂志文章,多中心研究

    doi:10.1016/j.thromres.2018.11.011

    authors: Zumbrunn B,Stalder O,Méan M,Limacher A,Tritschler T,Rodondi N,Aujesky D

    更新日期:2019-01-01 00:00:00

  • The effect of dabigatran on thrombin generation and coagulation assays in rabbit and human plasma.

    abstract:OBJECTIVES:Dabigatran etexilate is widely used for stroke prevention in the patients with atrial fibrillation. The anticoagulation activity of dabigatran is not necessary monitored in routine clinical practice. We aimed to study the effect of dabigatran on thrombin generation (TG) and coagulation assays in rabbit and h...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2018.03.012

    authors: Zhang C,Zhang P,Li H,Han L,Zhang L,Zhang L,Yang X

    更新日期:2018-05-01 00:00:00

  • Antithrombin III deficiency as a risk factor for catheter-related central vein thrombosis in cancer patients.

    abstract::The fibrin sleeve of venous catheters (VC) and parietal thrombi represent frequent and dangerous side-effects of central venous catheterization (CVC), due to the risk of embolism. Reduced levels of coagulation clotting factors inhibitors (such as Antithrombin III) are known to be associated with increased thrombogenic...

    journal_title:Thrombosis research

    pub_type: 临床试验,杂志文章

    doi:10.1016/0049-3848(95)00041-0

    authors: De Cicco M,Matovic M,Balestreri L,De Angelis V,Fracasso A,Morassut S,Coran F,Babare R,Buonadonna A,Testa V

    更新日期:1995-04-15 00:00:00

  • Comparison of antithrombin activity of the polysulphate chitosan derivatives in in vivo and in vitro system.

    abstract::In order to choose the proper method for evaluating the antithrombin activity in samples of chitosan polysulphate (CP) with different polymerization degrees and sulphation degrees, we estimated the ability of direct anticoagulants to depress the coagulability of recalcified sheep blood using the third international he...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(01)00266-3

    authors: Drozd NN,Sher AI,Makarov VA,Galbraikh LS,Vikhoreva GA,Gorbachiova IN

    更新日期:2001-06-01 00:00:00

  • The effect of calcium ionophore A23187 on tissue factor activity and mRNA in endothelial cells.

    abstract::Tissue factor (TF) is an integral membrane glycoprotein that serves as a cofactor for blood coagulation factor VIIa. The induction of TF on the surface of endothelial cells is initiated by various kinds of stimuli including lipopolysaccharide (LPS), interleukin-1 beta (IL-1 beta), and tumor necrosis factor alpha (TNF ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90002-7

    authors: Wakita K,Stearns-Kurosawa DJ,Marumoto Y

    更新日期:1994-04-15 00:00:00

  • Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study.

    abstract:BACKGROUND:Predictors of venous thromboembolism (VTE) after trauma are uncertain. OBJECTIVE:To identify independent predictors of VTE after acute trauma. METHODS:Using Rochester Epidemiology Project (REP) resources, we identified all Olmsted County, MN residents with objectively-diagnosed incident VTE within 92days a...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2016.03.026

    authors: Park MS,Perkins SE,Spears GM,Ashrani AA,Leibson CL,Boos CM,Harmsen WS,Jenkins DH,Bailey KR,Ballman KV,Heit JA

    更新日期:2016-08-01 00:00:00

  • Phosphatidylcholine is the major phospholipid providing arachidonic acid for prostacyclin synthesis in thrombin-stimulated human endothelial cells.

    abstract::Upon incubation for 24 hours with [3H]arachidonic acid (AA, 1 mu Ci/ml), cultured endothelial cells from human umbilical vein incorporated one half of the added radioactivity, mostly into phospholipids (83% of the total cell radioactivity). Distribution of the label between the various phospholipid classes was found t...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90068-9

    authors: Thomas JM,Hullin F,Chap H,Douste-Blazy L

    更新日期:1984-04-15 00:00:00

  • Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary embolism.

    abstract:BACKGROUND:Troponin I (cTnI), myoglobin, heart-type fatty acid binding protein (H-FABP), and natriuretic peptides (BNP, NTproBNP) were all reported to be elevated in patients with pulmonary embolism (PE). METHODS:To assess the correlation between the aforementioned markers and helical computed tomography (hCT) right v...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2007.07.003

    authors: Vuilleumier N,Righini M,Perrier A,Rosset A,Turck N,Sanchez JC,Bounameaux H,Le Gal G,Mensi N,Hochstrasser D

    更新日期:2008-01-01 00:00:00

  • Reduction in epistaxis and emergency department visits in patients taking warfarin after implementation of an education program.

    abstract:BACKGROUND:Anticoagulated patients are often seen unnecessarily in the emergency department (ED) for epistaxis, leading to increased healthcare costs. Patients are often unaware of preventative and management techniques for handling epistaxis in the home. METHODS:In 2016, the Michigan Anticoagulation Quality Improveme...

    journal_title:Thrombosis research

    pub_type: 信件

    doi:10.1016/j.thromres.2021.01.007

    authors: Neshewat J,Wasserman A,Alexandris-Souphis C,Haymart B,Feldeisen D,Kong X,Harvey RS,Pynnonen M,Froehlich JB,Kline-Rogers E,Barnes GD

    更新日期:2021-01-16 00:00:00

  • The thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis.

    abstract:BACKGROUND AND PURPOSE:Miniplasmin was a des-kringle variant of plasminogen with potential pharmacological application. We investigated the thrombolytic effect of miniplasmin in a canine model of femoral artery thrombosis. METHODS:In anesthetized dogs, a stable occlusive thrombus was formed by mechanical and electroly...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.01.007

    authors: Fu J,Ren J,Zou L,Bian G,Li R,Lu Q

    更新日期:2008-01-01 00:00:00

  • Elevated levels of platelet microparticles in carotid atherosclerosis and during the postprandial state.

    abstract:BACKGROUND:Platelet microparticles (PMPs) possess proatherogenic and procoagulant properties which may play a role in atherogenesis and subsequent thromboembolic complications. The present study was conducted to investigate the possible relationship between carotid atherosclerosis and plasma concentrations of PMPs, and...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2008.10.016

    authors: Michelsen AE,Notø AT,Brodin E,Mathiesen EB,Brosstad F,Hansen JB

    更新日期:2009-04-01 00:00:00

  • The interaction of platelet proteins with three fibroblast-derived collagenases.

    abstract::Three collagenases were purified from the culture medium of human skin fibroblasts using ammonium sulfate fractionation, ion-exchange chromatography and gel filtration. The cationic collagenase had a molecular weight of 42,000; two anionic collagenases had molecular weights of 63,000 and 115,000. Preincubation of the ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(84)90211-1

    authors: Pisoni R,Ciaglowski RE,Brown RK,Walz DA

    更新日期:1984-07-15 00:00:00

  • Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism.

    abstract::Mild hyperhomocysteinemia is recognized as a risk factor for venous thromboembolism (VTE), though its role in the thrombogenic processes is not understood. Its possible association with impaired fibrinolysis was investigated in 157 patients (61 women, 96 men) below the age of 60 years (43+/-11, mean+/-SD) with a histo...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00324-8

    authors: Bozic M,Stegnar M,Fermo I,Ritonja A,Peternel P,Stare J,D'Angelo A

    更新日期:2000-11-15 00:00:00

  • Interventional treatment of venous thromboembolism: a review.

    abstract::Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), is the third most common cardiovascular disease after coronary artery disease and cerebrovascular disease and is responsible for significant morbidity and mortality in the general population. Full dose anticoagulation is th...

    journal_title:Thrombosis research

    pub_type: 杂志文章,评审

    doi:10.1016/j.thromres.2011.11.003

    authors: Imberti D,Ageno W,Manfredini R,Fabbian F,Salmi R,Duce R,Gallerani M

    更新日期:2012-04-01 00:00:00

  • Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.

    abstract::Using a stable cross-linked SAK/plg complex, the effects of alpha 2-plasmin inhibitor on plasminogen activation by SAK were investigated. alpha 2-Plasmin inhibitor inhibited dose-dependently plasminogen activation by the SAK/plg complex. When FCB-2 or EACA was added to the reaction mixture of SAK/plg complex and alpha...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(94)90191-0

    authors: Okada K,Nonaka T,Matsumoto H,Fukao H,Ueshima S,Matsuo O

    更新日期:1994-10-15 00:00:00

  • Should we abandon the APTT for monitoring unfractionated heparin?

    abstract:INTRODUCTION:The activated partial thromboplastin time (APTT) is commonly used to monitor unfractionated heparin (UFH) but may not accurately measure the amount of heparin present. The anti-Xa assay is less susceptible to confounding factors and may be a better assay for this purpose. MATERIALS AND METHODS:The validit...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2017.07.006

    authors: Arachchillage DRJ,Kamani F,Deplano S,Banya W,Laffan M

    更新日期:2017-09-01 00:00:00

  • Acute carotid artery occlusive thrombosis and its pharmacological prevention in the rabbit.

    abstract::A simple and reproducible method to induce an occlusive thrombus in rabbit carotid artery is reported. Rabbits were anesthetized and prepared to record arterial pressure, heart rate, and carotid blood flow. A critical stenosis of a damaged carotid artery was obtained using an external plastic cylinder. Complete occlus...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(91)90147-o

    authors: Bevilacqua C,Finesso M,Prosdocimi M

    更新日期:1991-05-15 00:00:00

  • Aggregated-disaggregated, refractory platelets retain sensitivity to ristocetin.

    abstract::The present investigation has used an aggregation-disaggregation-reaggregation model to determine if exposure to potent aggregating agents causing a refractory state in deaggregated platelets results in down-regulation and clearance of GPIb/IX, the receptor for von willebrand factor. Thrombin, the thrombin receptor ac...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(96)00185-5

    authors: White JG,Rao GH

    更新日期:1996-11-15 00:00:00

  • Role of protein kinase C in U46619-induced platelet shape change, aggregation and secretion.

    abstract::Stimulation of rat platelets with U46619 induced Ca2+ mobilization and platelet shape change, but aggregation and secretion were induced when platelets were stimulated with U46619 plus phorbol 12-myristate 13-acetate (PMA). However, stimulation of rabbit platelets with U46619 induced all the three platelet responses. ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/0049-3848(89)90171-0

    authors: Nakano T,Hanasaki K,Arita H

    更新日期:1989-10-15 00:00:00

  • The role of prothrombotic mutations in patients with Buerger's disease.

    abstract::Thromboangiitis obliterans (TAO), or Buerger's disease, is a segmental occlusive inflammatory disorder of the arteries and veins, and etiopathogenesis is still obscure. In the present study we investigated the prevalence of prothrombin 20210 G-->A, factor V 1691 G-->A (Factor V Leiden), and factor V 4070 A-->G (His 12...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/s0049-3848(00)00310-8

    authors: Avcu F,Akar E,Demirkiliç U,Yilmaz E,Akar N,Yalçin A

    更新日期:2000-11-01 00:00:00

  • Mutations within the cyclooxygenase-1 gene in aspirin non-responders with recurrence of stroke.

    abstract:INTRODUCTION:Aspirin is a common antiplatelet drug used in the prevention of ischemic stroke due to its inhibitory effect on platelet cyclooxygenase-1 (Cox-1). Patients can be categorized as either aspirin 'responders' or 'non-responders' depending on whether they are protected against a secondary stroke event or not. ...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2003.12.005

    authors: Hillarp A,Palmqvist B,Lethagen S,Villoutreix BO,Mattiasson I

    更新日期:2003-01-01 00:00:00

  • No evidence for increased platelet activation in patients with hepatitis B- or C-related cirrhosis and hepatocellular carcinoma.

    abstract:INTRODUCTION:Cancer is a major risk factor for developing venous thromboembolism (VTE). Plasma hypercoagulability is an established risk factor for cancer-related VTE. In addition, thrombocytosis and hyperreactive platelets have been implicated in VTE and cancer progression. Cirrhosis is associated with changes in plat...

    journal_title:Thrombosis research

    pub_type: 杂志文章

    doi:10.1016/j.thromres.2014.11.016

    authors: Alkozai EM,Porte RJ,Adelmeijer J,Zanetto A,Simioni P,Senzolo M,Lisman T

    更新日期:2015-02-01 00:00:00